Followers | 230 |
Posts | 14768 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
Wednesday, August 18, 2021 5:17:04 PM
So long as the Northwest insiders continue to be patriotic (and look out for the company first, as opposed to their own) and lock up their options and warrants, they leave a fair amount of sellable shares on the table… somewhere around 75 million, give or take.
Upon release of trial data, these shares could be sold to raise a significant amount of funds right away.
In fact, just 30 million of those shares at $10 would raise $300 million.
And there is still more money to be raised, as that doesn’t count the number of warrants that are currently exercisable that likely some holders will likely want to the exercise and start the year-long clock on.
And all of this after-clinical-trial-release-financing could take place well before any shareholder vote to increase the limit or for a reverse split was required.
Below are the figures I based my estimates on:
In the Q, the warrant liability listed the total fair value of the warrants at $341,459,000 on June 30, 2021.
The share price was $1.47 and the strike price showed of $0.26.
So $1.47 - $0.26 = $1.21
$341,459,000 / $1.21 = 282,197,520 warrants
282,197,520 warrants
minus
58,800,000 not exercisable or blocked warrants
=
223,397,520 currently exercisable warrants
Moving on to Options
272,701,000 currently vested options
minus
245,200,000 vested options currently not exercisable
=
27,501,000 exercisable vested options
On August 13, 2021, there were
872,440436 total shares outstanding
plus
223,397,520 exercisable warrants
plus
27,501,000 exercisable options
=
1,123,338,956 total common stock and exercisable options and warrants
leaving approximately 76.6 million currently available to sell.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM